Key result
Aerobic interval training with intermittent myocardial ischaemia increased peak workload by 28.6% and VO2 peak by 35.7% in a patient with refractory angina, without adverse effects.
Why the study?
Does high-intensity aerobic interval training involving intermittent myocardial ischemia improve exercise capacity and symptoms in a patient with refractory angina?
Case Report (n=1)
No
Does high-intensity aerobic interval training involving intermittent myocardial ischemia improve exercise capacity and symptoms in a patient with refractory angina?
Effect estimate: +28.6%
Absolute Event Rate: 90% vs 70%
Aerobic interval training with intermittent myocardial ischemia may be a safe and effective therapeutic alternative to improve exercise capacity and symptoms in patients with refractory angina unsuitable for revascularization.
High-intensity interval training was associated with improved exercise capacity in refractory angina; leaves open safety and efficacy beyond this case.
A 72-year-old man daily suffered from a refractory angina consecutive to a diffuse coronary artery disease despite optimal medical management. Revascularization could not be performed because of a severe thrombopenia. He was referred to our outpatient cardiac rehabilitation programme where he was candidate for 20 sessions, three times a week, of high-intensity aerobic interval training involving brief episodes of regressive myocardial ischaemia. After 7 weeks, exercise capacity (+28.5%), VO2 peak (35.7%), and ischaemic threshold increased while clinical status and quality of life improved. No adverse effect was reported. Aerobic interval training with myocardial ischaemia might be a therapeutic alternative in refractory angina.
No takes yet. Share an insight, caveat, or question.
Corré et al. (2021) conducted a case report in Refractory angina (n=1). Aerobic interval training with intermittent myocardial ischaemia was evaluated on Peak workload (+28.6%). Aerobic interval training with intermittent myocardial ischaemia increased peak workload by 28.6% and VO2 peak by 35.7% in a patient with refractory angina, without adverse effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: